603456.SS · 九洲药业
China A-shares · RS rating 91 · As of 2026-10-14
| Price | 16.76 CNY |
|---|---|
| 1-day change | +1.0% |
| RS rating (overall / 1M / 3M / 12M) | 91 / 95 / 89 / 55 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 32 / 40 / 29 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +14.5% |
| Distance from 52-week high | +23.4% |
| Market cap (USD) | $2.1B |